Deleterious network: A testable pathogenetic concept of Alzheimer's disease

被引:0
|
作者
Ying, WH
机构
关键词
Alzheimer's disease; pathogenesis; amyloid precursor protein metabolism; oxidative damage; energy metabolism; calcium homeostasis;
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cumulative evidence has indicated that a deleterious network is formed on the basis of close interactions among abnormal amyloid precursor protein (APP) metabolism, oxidative damage, compromised energy metabolism and impaired calcium homeostasis. A unifying hypothesis - the deleterious network hypothesis of Alzheimer's disease (AD)- proposes that the deleterious network, not any single factor, is the common pathway of AD. Aging and multiple genetic or environmental factors could trigger the network by promoting the occurrence of one or more of the key detrimental factors, leading to a number of pathological changes of the disorder. This new hypothesis appears to unify some major theories of AD, providing a sound basis for consistent explanations to a large variety of the observations about the disorder. In this article up-to-date delineation of the novel theory is given. Three types of studies are also proposed for further determining the validity of the new hypothesis. Based on this theory, it is suggested that combinative applications of the approaches which can reduce the incidence of the four key pathological factors could become a new therapeutic strategy of AD.
引用
收藏
页码:242 / 253
页数:12
相关论文
共 50 条
  • [21] Immunological concept in the treatment of Alzheimer's disease
    Solomon, B
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (02) : 163 - 167
  • [22] Preclinical Alzheimer's disease: a valid concept
    Jack, Clifford R., Jr.
    LANCET NEUROLOGY, 2020, 19 (01): : 31 - 31
  • [23] Selenotranscriptome network in Alzheimer's disease
    Cardoso, B. R.
    Day, K.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2024, 83 (OCE1)
  • [25] Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease
    Vacirca, D.
    Delunardo, F.
    Matarrese, P.
    Colasanti, T.
    Margutti, P.
    Siracusano, A.
    Pontecorvo, S.
    Capozzi, A.
    Sorice, M.
    Francia, A.
    Malorni, W.
    Ortona, E.
    NEUROBIOLOGY OF AGING, 2012, 33 (04) : 753 - 766
  • [26] Decrease of cellular immune activity: A possible pathogenetic factor in Alzheimer's disease
    Richartz, ER
    Schott, KJ
    Batra, A
    NEUROBIOLOGY OF AGING, 2004, 25 : S533 - S534
  • [27] Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression
    Colasanti, Tania
    Barbati, Cristiana
    Rosano, Giuseppe
    Malorni, Walter
    Ortona, Elena
    AUTOIMMUNITY REVIEWS, 2010, 9 (12) : 807 - 811
  • [28] Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease
    Shade, Ronnie D. D.
    Ross, Jennifer A. A.
    Van Bockstaele, Elisabeth J. J.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [29] A Qualitative Assessment of the Concept of Dependence in Alzheimer's Disease
    Frank, Lori
    Howard, Kellee
    Jones, Roy
    Lacey, Loretto
    Leibman, Chris
    Lleo, Alberto
    Mannix, Sally
    Mucha, Lisa
    McLaughlin, Trent
    Zarit, Steve
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (03): : 239 - 247
  • [30] Rethinking on the concept of biomarkers in preclinical Alzheimer's disease
    Berti, Valentina
    Polito, Cristina
    Lombardi, Gemma
    Ferrari, Camilla
    Sorbi, Sandro
    Pupi, Alberto
    NEUROLOGICAL SCIENCES, 2016, 37 (05) : 663 - 672